MedVadis Research
Hospitals & Physicians Clinics · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
281 Winter St Fl 2, Waltham, Massachuset...Phone Number
(781) 373-2940Website
www.medvadis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About MedVadis Research
MedVadis Research is a clinical trial research center based in Waltham, Massachusetts, dedicated to the advancement and discovery of new medical treatments since 1996. The center has conducted over 300 clinical trials focusing on various medical conditions, including migraines, Alzheimer's disease, and chronic pain. Following a merger with Boston Advanced Medicine in 2019, MedVadis expanded its research participation opportunities and access to treatment for chronic pain and headaches. The facility aims to engage the local community in understanding health issues and developing innovative solutions.Explore more
MedVadis Research Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MedVadis Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if MedVadis Research is spiking on competitors!
Funding: Get notified immidiatlly once MedVadis Research has new funding data
Click to see if MedVadis Research had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at MedVadis Research
Earning: See what the market has to say on MedVadis Research recently announced quarterly report
MedVadis Research, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when MedVadis Research launches new products
Check if MedVadis Research has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to MedVadis Research
Compare insights from companies similar to MedVadis Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MedVadis Research is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
MedVadis Research is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about MedVadis Research.
MedVadis Research Tech Stack
A closer look at the technologies used by MedVadis Research
MedVadis Research News & Media
MedVadis Research Expands to Include Studies on Alzheimer's and Dementia
BOSTON, Feb. 14, 2022 /PRNewswire/ -- MedVadis Research, an independent clinical trial research center, announced today that it is broadening its studies to address Alzheimer's disease and other dementias. In collaboration with the Global Alzheimer Platform Foundation's network of...
Read more news
Top Hospitals & Physicians Clinics Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MedVadis Research
Sign Up For FreeTo access detailed company insights
MedVadis Research is a clinical trial research center based in Waltham, Massachusetts, dedicated to the advancement and discovery of new medical treatments since 1996. The center has conducted over 300 clinical trials focusing on various medical conditions, including migraines, Alzheimer's disease, and chronic pain. Following a merger with Boston A... Read More
